Rapid Detection and Quantification of RNA of Ebola and Marburg Viruses, Lassa Virus, Crimean-Congo Hemorrhagic Fever Virus, Rift Valley Fever Virus, Dengue Virus, and Yellow Fever Virus by Real-Time Reverse Transcription-PCR

ABSTRACT Viral hemorrhagic fevers (VHFs) are acute infections with high case fatality rates. Important VHF agents are Ebola and Marburg viruses (MBGV/EBOV), Lassa virus (LASV), Crimean-Congo hemorrhagic fever virus (CCHFV), Rift Valley fever virus (RVFV), dengue virus (DENV), and yellow fever virus (YFV). VHFs are clinically difficult to diagnose and to distinguish; a rapid and reliable laboratory diagnosis is required in suspected cases. We have established six one-step, real-time reverse transcription-PCR assays for these pathogens based on the Superscript reverse transcriptase-Platinum Taq polymerase enzyme mixture. Novel primers and/or 5′-nuclease detection probes were designed for RVFV, DENV, YFV, and CCHFV by using the latest DNA database entries. PCR products were detected in real time on a LightCycler instrument by using 5′-nuclease technology (RVFV, DENV, and YFV) or SybrGreen dye intercalation (MBGV/EBOV, LASV, and CCHFV). The inhibitory effect of SybrGreen on reverse transcription was overcome by initial immobilization of the dye in the reaction capillaries. Universal cycling conditions for SybrGreen and 5′-nuclease probe detection were established. Thus, up to three assays could be performed in parallel, facilitating rapid testing for several pathogens. All assays were thoroughly optimized and validated in terms of analytical sensitivity by using in vitro-transcribed RNA. The ≥95% detection limits as determined by probit regression analysis ranged from 1,545 to 2,835 viral genome equivalents/ml of serum (8.6 to 16 RNA copies per assay). The suitability of the assays was exemplified by detection and quantification of viral RNA in serum samples of VHF patients.

[1]  D. Simpson,et al.  CONGO/CRIMEAN HÆMORRHAGIC FEVER IN DUBAI An Outbreak at the Rashid Hospital , 1980, The Lancet.

[2]  S. Read,et al.  LightCycler Multiplex PCR for the Laboratory Diagnosis of Common Viral Infections of the Central Nervous System , 2001, Journal of Clinical Microbiology.

[3]  D. Brown,et al.  Early diagnosis of Lassa fever by reverse transcription-PCR , 1994, Journal of clinical microbiology.

[4]  F. Hufert,et al.  Detection of Lassa virus RNA in specimens from patients with Lassa fever by using the polymerase chain reaction , 1990, Journal of clinical microbiology.

[5]  M. Bouloy,et al.  Quantitative Real-Time PCR Detection of Rift Valley Fever Virus and Its Application to Evaluation of Antiviral Compounds , 2001, Journal of Clinical Microbiology.

[6]  P E Klapper,et al.  Multiplex PCR: Optimization and Application in Diagnostic Virology , 2000, Clinical Microbiology Reviews.

[7]  G. Maupin,et al.  An outbreak of Crimean-Congo hemorrhagic fever in the United Arab Emirates, 1994-1995. , 1997, The American journal of tropical medicine and hygiene.

[8]  J. Jones Lassa fever imported to England. , 2000, Communicable disease report. CDR weekly.

[9]  K. Livak,et al.  Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization. , 1995, PCR methods and applications.

[10]  M. Turell,et al.  Detection of Rift Valley fever virus in mosquitoes by RT-PCR. , 1997, Molecular and cellular probes.

[11]  M. Dietel,et al.  A haemorrhagic fever from the Côte d'lvoire , 1999, The Lancet.

[12]  L. Hutwagner,et al.  Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice , 1995, BMJ.

[13]  A. Widmer,et al.  Molecular detection and characterization of yellow fever virus in blood and liver specimens of a non‐vaccinated fatal human case , 1997, Journal of medical virology.

[14]  G. Siegl,et al.  A nested-PCR assay for the simultaneous amplification of HSV-1, HSV-2, and HCMV genomes in patients with presumed herpetic CNS infections. , 1998, Journal of virological methods.

[15]  P. Rollin,et al.  Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients. , 1999, The Journal of infectious diseases.

[16]  K. Morita,et al.  Rapid identification of dengue virus serotypes by using polymerase chain reaction , 1991, Journal of clinical microbiology.

[17]  A. W. Woodruff,et al.  Lassa fever in Britain: an imported case. , 1973, British medical journal.

[18]  T. Hawn,et al.  Emerging Infectious Diseases , 2011, Berkowitz’s Pediatrics: A Primary Care Approach.

[19]  M. Dietrich,et al.  Clinical observations in 42 patients with Lassa fever. , 1980, Tropenmedizin und Parasitologie.

[20]  J. T. ter Meulen,et al.  Imported tropical virus infections in Germany. , 1996, Archives of virology. Supplementum.

[21]  S. Günther,et al.  Lassa fever encephalopathy: Lassa virus in cerebrospinal fluid but not in serum. , 2001, The Journal of infectious diseases.

[22]  R. Abramson,et al.  Detection of specific polymerase chain reaction product by utilizing the 5'----3' exonuclease activity of Thermus aquaticus DNA polymerase. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[23]  E. Seifried,et al.  Evaluation of a new PCR assay with competitive internal control sequence for blood donor screening , 2000, Transfusion.

[24]  L. Peruski,et al.  Development and Evaluation of Serotype- and Group-Specific Fluorogenic Reverse Transcriptase PCR (TaqMan) Assays for Dengue Virus , 2001, Journal of Clinical Microbiology.

[25]  D. Norwood,et al.  Development and Evaluation of a Fluorogenic 5′ Nuclease Assay To Detect and Differentiate between Ebola Virus Subtypes Zaire and Sudan , 2001, Journal of Clinical Microbiology.

[26]  S. Oka,et al.  An imported case of Lassa fever with late appearance of polyserositis. , 1988, The Journal of infectious diseases.

[27]  P. Jahrling,et al.  Pathogenesis of viral hemorrhagic fevers: Rift Valley fever and Lassa fever contrasted. , 1989, Reviews of infectious diseases.

[28]  J. Lewis,et al.  Probit Analysis (3rd ed). , 1972 .

[29]  J. McCormick,et al.  Diagnosis of Ebola haemorrhagic fever by RT‐PCR in an epidemic setting , 2000, Journal of medical virology.

[30]  T. B. Morrison,et al.  Quantification of low-copy transcripts by continuous SYBR Green I monitoring during amplification. , 1998, BioTechniques.

[31]  C. Goldsmith,et al.  Replicate PCR Testing and Probit Analysis for Detection and Quantitation of Chlamydia pneumoniae in Clinical Specimens , 2001, Journal of Clinical Microbiology.

[32]  A. Sanchez,et al.  Detection and molecular characterization of Ebola viruses causing disease in human and nonhuman primates. , 1999, The Journal of infectious diseases.

[33]  S. Kehl,et al.  Evaluation of the Hexaplex Assay for Detection of Respiratory Viruses in Children , 2001, Journal of Clinical Microbiology.

[34]  A. Heath,et al.  Establishment of the First International Standard for Nucleic Acid Amplification Technology (NAT) Assays for HCV RNA , 1999, Vox Sanguinis.

[35]  Y. Hirshaut,et al.  Two dimensional view of combination chemotherapy in vitro , 1978, American journal of hematology.

[36]  D. Fleming,et al.  Multiplex reverse transcription-PCR for surveillance of influenza A and B viruses in England and Wales in 1995 and 1996 , 1997, Journal of clinical microbiology.

[37]  Y. Wu,et al.  Performance characteristics of the COBAS AmpliScreen HIV‐1 test, version 1.5, an assay designed for screening plasma mini‐pools , 2001, Transfusion.

[38]  A. Heath,et al.  An international collaborative study to establish the 1st international standard for HIV-1 RNA for use in nucleic acid-based techniques. , 2001, Journal of virological methods.

[39]  S. Kwok,et al.  Avoiding false positives with PCR , 1989, Nature.